State Of Wyoming Madrigal Pharmaceuticals, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $1,799 - $3,106	31 Added 31.96%	128 $9,000
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $894 - $1,630	16 Added 19.75%	97 $10,000
Q4 2021 Feb 11, 2022	SELL	$72.34 - $95.09 $289 - $380	-4 Reduced 4.71%	81 $7,000
Q3 2021 Feb 11, 2022	SELL	$78.35 - $105.02 $3,212 - $4,305	-41 Reduced 32.54%	85 $7,000
Q2 2021 Feb 11, 2022	BUY	$97.2 - $137.59 $6,512 - $9,218	67 Added 113.56%	126 $12,000
Q1 2021 Feb 08, 2022	BUY	$108.54 - $125.2 $6,403 - $7,386	59 New	59 $7,000

338

22.7M

757K

960K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.77B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.